Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease

Background—The relapse rate after steroid induced remission in Crohn's disease is high. 
Aims—To test whether oral pH modified release budesonide (3 × 1 mg/day) reduces the relapse rate and to identify patient subgroups with an increased risk of relapse. 
Methods—In a multicentre, randomised, d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gross, V, Andus, T, Ecker, K, Raedler, A, Loeschke, K, Plauth, M, Rasenack, J, Weber, A, Gierend, M, Ewe, K, Scholmerich, J, Budesonide, S
Formato: Artigo
Idioma:Inglês
Publicado em: 1998
Assuntos:
Inflammation and Inflammatory Bowel Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1727061/
https://ncbi.nlm.nih.gov/pubmed/9616309
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados